IPT For Cancer
Insulin Potentiated Therapy (IPT) (IPT-LD) and Cancer
What is IPT?
IPT is a therapeutic regime designed to increase the efficacy of conventional chemotherapeutic drugs while decreasing toxicity. IPT involves the use of intravenous insulin in combination with chemotherapy to selectively increase the amount of medication delivered into cancer cells so that less chemotherapy is needed to obtain desired therapeutic results. The goal is to kill cancer cells while minimizing damage to the normal tissues.
Generally FDA approved chemotherapeutic drugs are used. However, natural substances may also be administered.
Intravenously administered insulin lowers normal blood sugar in the body. While the blood sugar concentration is low, chemotherapeutic drugs are administered and enter cancer cells to a much greater extent than they do normal cells. With greater amounts of chemotherapeutic drugs entering cancer cells and lesser amounts entering normal cells, bodily toxicity and resultant side effects are reduced.
Typically with IPT administration only 10-15% of the customary amount of conventional chemotherapeutic agents is needed to kill cancer cells. The result is that the rest of the body, including the immune system, is exposed only to 10-15% of the toxicity of conventionally administered chemotherapy, eliminating or significantly reducing of side effects.
The treatment routinely involves the patient comfortably reclining in a chair in the outpatient setting receiving an infusion of water and minerals administered intravenously. Insulin is added to the intravenous infusion resulting in a temporary lowering of blood sugar which is monitored every few minutes until the desired blood sugar level is reached. Approximately one half hour after insulin is injected while the sugar concentration is at its lowest, small amounts of chemotherapeutic medicines are administered intravenously. Subsequently, blood sugar levels are brought into balance with the infused dextrose; oral beverages and healthy foods. The treatment typically takes just over one hour.
IPT is also referred to as IPT-LD, the letters LD meaning low dose. The objective is to achieve anticancer effects with less chemotherapeutic medication, fewer side effects, reduced organ damage, and less compromise of the immune system. Strong immune function is needed to fight cancer.
To download a copy of "The Case for Intravenous EDTA Chelation Therapy", click on the book cover. This will take you to a page where you can read some of the background information about this therapy and also download a free copy of the book. The book is reproduced word for word except for changes in contact information for organizations.
Wishing you the VERY best of health! Dr. Martin Dayton